Dr. Katrina Elaine Abuabara, MD

Dr. Abuabara practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Dr. Abuabara's NPI, 1558689216, was assigned on May 5, 2010. Dr. Abuabara graduated from Harvard Medical School in 2010. Dr. Abuabara's Pennsylvania license number on file is MD452542.

Dr. Abuabara's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Dr. Abuabara's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Dr. Abuabara to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Abuabara practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Abuabara's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Abuabara is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Abuabara's licenses on file in 2 states: Pennsylvania and California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, contact dermatitis, hives, scalp rash and skin cyst among the conditions Dr. Abuabara treats.

CMS data shows 242 Medicare services from Dr. Abuabara across 7 procedure codes in 2024, for 79 Medicare patients. Medicare paid $9,048 for them. Every service was in an office.

CMS counts 79 Medicare patients who saw Dr. Abuabara in 2024. The largest group is 65 to 74, with 31 patients. 65% of them have high cholesterol, and 56% have high blood pressure. 34% are also on Medicaid. Their average risk score is 1.16, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Abuabara's median patient age at 67, with 64% women.

In 2024, Dr. Abuabara wrote 175 Medicare Part D claims for 50 patients. 89% of them were for generic drugs. CMS names the drug for 84 of them, across 6 drugs with 11 or more claims each, at $50,019 in total drug cost. In 2022, CMS named 47 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Abuabara for performance year 2024, reported as part of a group. Dr. Abuabara accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 70 procedures of removal of skin lesions by Dr. Abuabara, more than 73% of the clinicians it reports for that procedure.

Dmand AI links 118 papers to Dr. Abuabara, published from 2006 to 2025. 2022 was the busiest year, with 11. The most frequent topics are Dermatitis, Atopic, United Kingdom and Eczema. Dr. Abuabara has published most often in Br J Dermatol. Dr. Abuabara's most frequent co-authors are Joel M. Gelfand, MD, David J. Margolis, MD and Faustine Dufka Ramirez, MD.

CMS Open Payments shows 23 general payments to Dr. Abuabara from 5 drug and device companies from 2023 to 2025. Consulting fees make up the largest share, 51% of the total. Sanofi and Genzyme US Companies paid the most, $14,380. It also lists 4 research payments totaling $1,727 from 2022 to 2023.

Dr. Abuabara graduated from Harvard Medical School in 2010.

Dr. Abuabara is in network with 8 carriers, including Aetna, Blue Cross Blue Shield of Michigan and Elevance. Medicare plans come from the most carriers, 4. Check the plan with the practice before a visit.